Abiomed Inc. (ABMD)
NASDAQ: ABMD
· Real-Time Price · USD
381.02
0.00 (0.00%)
At close: Dec 21, 2022, 10:00 PM
Abiomed Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 106.13M | 54.55M | 60.33M | 45.75M | 56.95M | -26.52M | 56.86M | 61.87M | 62.21M | 44.59M |
Depreciation & Amortization | 6.72M | 6.62M | 7.29M | 6.93M | 6.97M | 6.91M | 6.83M | 6.13M | 5.66M | 5.48M |
Stock-Based Compensation | 16.01M | 13.36M | 11.99M | 12.38M | 15.75M | 12.61M | 13.29M | 12.86M | 11.56M | 9.3M |
Other Working Capital | -22.75M | 6.28M | 10.93M | 18.31M | -11.08M | -25.01M | 4.68M | 3.03M | 175K | -18.38M |
Other Non-Cash Items | -75.43M | 611K | 2.03M | 12.15M | -1.18M | 82.85M | -3.22M | -4.3M | -6.01M | -20.52M |
Deferred Income Tax | -1.04M | -6.37M | -4.64M | -1.14M | 1.89M | 6.3M | 6.46M | 8.73M | 1.24M | 12.95M |
Change in Working Capital | -38.98M | -671K | 1.97M | 14.42M | -19.81M | -26.78M | 6.26M | -6.15M | 2.54M | -20.04M |
Operating Cash Flow | 13.42M | 68.1M | 78.97M | 90.49M | 60.57M | 55.36M | 86.47M | 79.14M | 77.21M | 31.76M |
Capital Expenditures | -5.61M | -6.78M | -14.89M | -6.48M | -7.22M | -7.17M | -26.11M | -7.72M | -9.51M | -10.04M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -82.82M | n/a | n/a | -236K | -51.95M |
Purchase of Investments | -151.1M | -126.49M | -217M | -251.22M | -194.81M | -142.89M | -68.45M | -216.2M | -233.59M | -64.07M |
Sales Maturities Of Investments | 258.28M | 141.38M | 139.32M | 77.67M | 202.69M | 123.82M | 58.31M | 118.13M | 148.27M | 139.81M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 101.57M | 8.11M | -92.57M | -180.02M | 660K | -109.06M | -36.24M | -105.79M | -95.07M | 13.76M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -112.11M | -14.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.31M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -110.18M | -23.94M | 4.75M | -6.16M | 6.68M | -7.47M | 5.37M | 1.28M | 5.45M | -20.16M |
Financial Cash Flow | -110.18M | -23.94M | 4.75M | -6.16M | 6.68M | -7.47M | 5.37M | 1.28M | 5.45M | -20.16M |
Net Cash Flow | 1.84M | 47.67M | -11.44M | -97.63M | 66.43M | -57.26M | 51.69M | -21.22M | -12.59M | 22.49M |
Free Cash Flow | 7.81M | 61.32M | 64.08M | 84.01M | 53.35M | 48.19M | 60.37M | 71.41M | 67.7M | 21.71M |